Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders

Blood
Christine Bellanné-ChantelotAlbert Najman

Abstract

To study the prevalence of the Val617Phe JAK2 mutation in familial cases of myeloproliferative disorder (MPD) and its possible implication as a predisposing genetic factor, we analyzed 72 families including 174 patients (81 polycythemia vera [PV], 68 essential thrombocythemia [ET], 11 myelofibrosis with myeloid metaplasia [MMM], 12 chronic myeloid leukemia), 1 systemic mastocytosis, and 1 chronic myelomonocytic leukemia (CMML). The JAK2 mutation was found in three quarters of patients with PV and MMM and in half of patients with ET. Among 46 families with at least 2 cases of PV, ET, or MMM, the JAK2 mutation was absent in 6 families, heterogeneously distributed in 18, and present in all MPD patients in 22. Among these 22 families, the absence of the JAK2 mutation both in purified T and B cells in 13 unrelated patients and the observation of variable ratios of the JAK2 mutant allele in patient leucocytes indicated that the Val617Phe JAK2 mutation was acquired in familial MPDs. The JAK2 mutation was present in natural killer cells in two thirds of tested patients (27 of 40), suggesting its occurrence in a multipotent hematopoietic progenitor cell. The analysis of the hematologic profile showed that the homozygous JAK2 mutation co...Continue Reading

Citations

Feb 27, 2010·International Journal of Hematology·François DelhommeauNicole Casadevall
Dec 13, 2012·International Journal of Hematology·Jelena D Milosevic, Robert Kralovics
Oct 4, 2012·European Journal of Human Genetics : EJHG·Kais HusseinHans Kreipe
Aug 30, 2008·Leukemia·R Kralovics
Apr 2, 2009·Nature Genetics·Peter J Campbell
Aug 28, 2007·Nature Reviews. Cancer·Ross L LevineD Gary Gilliland
Sep 14, 2007·Leukemia·C Bellanné-ChantelotUNKNOWN French group on myeloproliferative disorders
May 29, 2009·The New England Journal of Medicine·François DelhommeauOlivier A Bernard
Dec 8, 2006·The New England Journal of Medicine·Peter J Campbell, Anthony R Green
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Hiroshi HaenoFranziska Michor
Nov 3, 2010·Genetic Testing and Molecular Biomarkers·Mona Wagdy Ayad, Dalia Nafea
Nov 30, 2006·Current Opinion in Hematology·Ross L Levine, D Gary Gilliland
Jan 10, 2013·Current Opinion in Hematology·Gabriela Soriano, Mark Heaney
Nov 21, 2007·Hematology·Radek Skoda
Dec 17, 2008·Hematology·Ross L Levine, Mark Heaney
Dec 17, 2009·Hematology·Radek C Skoda
Dec 17, 2009·Hematology·Philip A Beer, Anthony R Green
Dec 14, 2011·Hematology·Nicholas C P Cross
Sep 10, 2008·Blood·Ross L Levine, D Gary Gilliland
Sep 10, 2008·Blood·Jerry L Spivak
Sep 10, 2008·Blood·Elisa RumiMario Lazzarino
Jul 1, 2009·Blood·Cécile Saint-MartinUNKNOWN French Group of Familial Myeloproliferative Disorders
Jan 11, 2007·Orphanet Journal of Rare Diseases·Jean B Brière
Dec 22, 2006·PloS One·Virginia M ZaleskasRichard A Van Etten
Jan 13, 2010·Haematologica·Radek C Skoda
Jan 1, 2011·Revista brasileira de hematologia e hemoterapia·Michelle Maccarini Barcelos, Maria Cláudia Santos-Silva
Jun 6, 2013·European Journal of Human Genetics : EJHG·Kais HusseinHolger Cario

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.